nicorandil has been researched along with Non-alcoholic Fatty Liver Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdallah, H; Abdel Maksoud, OM; Bastawy, N; Ibrahim, W; Morsi, H; Rashed, LA; Soliman, GF | 1 |
| Elshazly, SM | 1 |
2 other study(ies) available for nicorandil and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
Interrelation of liver vascularity to non-alcoholic fatty liver through a comparative study of the vasodilator effect of carvedilol or nicorandil in rats.
Topics: Adrenergic beta-Antagonists; Animals; Carvedilol; Liver; Male; Nicorandil; Non-alcoholic Fatty Liver Disease; Rats; Rats, Sprague-Dawley; Vasodilator Agents | 2019 |
Ameliorative effect of nicorandil on high fat diet induced non-alcoholic fatty liver disease in rats.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Biomarkers; Blood Glucose; Body Weight; Cholesterol; Cytoprotection; Diet, High-Fat; Drug Interactions; Gene Expression Regulation, Enzymologic; Homeostasis; Insulin; Insulin Resistance; Liver; Male; NF-kappa B; Nicorandil; Nitric Oxide Synthase Type III; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Pioglitazone; Rats; Rats, Wistar; Thiazolidinediones; Triglycerides; Tumor Necrosis Factor-alpha | 2015 |